Sunny Pharmtech Inc. (TPEX:6676)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.15
-0.30 (-2.62%)
Sep 15, 2026, 1:34 PM CST

Sunny Pharmtech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
91.3147.77138.02270.56222.63229
Short-Term Investments
----48.5112.5
Cash & Short-Term Investments
91.3147.77138.02270.56271.14241.5
Cash Growth
17.17%-65.39%-48.98%-0.21%12.27%-0.09%
Accounts Receivable
60.6964.5649.3456.3528.7763.63
Other Receivables
0.210.672.260.81.787.17
Receivables
60.965.2351.657.1530.5570.8
Inventory
77.5580.14123.4997.0471.9497.6
Prepaid Expenses
40.8847.2148.6428.6521.7518.4
Other Current Assets
3.17.13.17.118.643.48
Total Current Assets
273.74247.44364.86460.49413.98471.78
Property, Plant & Equipment
965.311,0031,0921,1561,102946.12
Long-Term Investments
-59.75----
Goodwill
25.2425.2425.2425.2425.2425.24
Other Intangible Assets
22.3728.8135.9642.7755.251.42
Other Long-Term Assets
34.3338.3469.227.9132.76100.16
Total Assets
1,3211,4031,5871,7121,6301,595

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.118.2816.8826.1312.3423.17
Accrued Expenses
33.4140.0446.9230.4323.8121.9
Short-Term Debt
-14320-19050
Current Portion of Long-Term Debt
20.7520.7520.7511.199.4420.09
Current Portion of Leases
4.464.144.173.943.162.79
Current Unearned Revenue
62.3530.6432.519.1912.4810.87
Other Current Liabilities
18.4125.2223.7320.9529.0336.89
Total Current Liabilities
142.48272.06164.94111.83280.25165.7
Long-Term Debt
265.94276.31297.06333.81327.24264.44
Long-Term Leases
41.2740.1744.3142.4932.8628.98
Long-Term Unearned Revenue
44.7952.0327.1317.0712.741.46
Other Long-Term Liabilities
7.247.247.247.247.247.68
Total Liabilities
501.72647.82540.68512.44660.32468.26

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,6971,4881,4881,4851,3851,385
Additional Paid-In Capital
63.3723.1721.69209.5316.9169.06
Retained Earnings
-940.89-765.01-462.96-496.17-432.85-427.84
Comprehensive Income & Other
-8.420.411.32--
Shareholders' Equity
819.27754.951,0471,200969.31,126
Total Liabilities & Equity
1,3211,4031,5871,7121,6301,595

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
332.42484.37386.29391.43562.69366.3
Net Cash (Debt)
-241.11-436.61-248.27-120.87-291.55-124.8
Net Cash Growth
------
Net Cash Per Share
-1.59-2.93-1.67-0.85-2.10-0.93
Filing Date Shares Outstanding
169.68148.84148.76148.53138.53138.53
Total Common Shares Outstanding
169.68148.84148.76148.53138.53138.53
Working Capital
131.26-24.62199.92348.66133.74306.08
Book Value Per Share
4.835.077.048.087.008.13
Tangible Book Value
771.66700.9985.491,132888.861,050
Tangible Book Value Per Share
4.554.716.627.626.427.58
Buildings
869.23867.78856.04847.93777.39702.81
Machinery
883.23871.52856.32822.27587.06512.13
Construction In Progress
1.680.142.694.44162.9164.94